http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6260059-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_440db8a3b6880a8d9160b5e0768b6626 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 |
| filingDate | 2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_309f123bd6078971f892b2150ee165e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a61e906c2e69e30a2a683c3d267566c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e4b6dcc4d1b118c26b593cee382ca9a |
| publicationDate | 2011-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-6260059-A2 |
| titleOfInvention | PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF BETAMETOSONE (STEROID INFLAMMATORY AGENT) AND METOCARBAMOL (MUSCLE RELAXING) AND ITS USE IN THE TREATMENT OF MUSCLE SKELETIC DISEASES |
| abstract | The present invention relates to a pharmaceutical composition composed of the synergistic combination of a steroidal anti-inflammatory agent, such as the active ingredient: Betamethasone, in the form of its pharmaceutically acceptable salts of Phosphate and Dipropionate, and a centrally acting muscle relaxant agent, as is the active substance: Metocarbamol, in addition to pharmaceutically acceptable excipients; same that are formulated in a single dose unit to be administered intramuscularly, used for the control and treatment of musculoskeletal inflammatory diseases that are accompanied by muscle contracture, which provides a greater therapeutic effect, a greater rapidity of action in less time and a reduction in the risk of side effects, such as drowsiness and ambulatory inability to perform daily activities. |
| priorityDate | 2007-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.